Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection

Cancer Medicine

Volumn 4, Issue 10, 2015, Pages 1589-1598

  Vriend, Henrike J ^a,b   Bogaards, Johannes A ^a   van Bergen, Jan E A M ^c,d   Brink, Antoinette A T P ^e   van den Broek, Ingrid V F ^a   Hoebe, Christian J P A ^e,f   King, Audrey J ^a   van der Sande, Marianne A B ^a,g   Wolffs, Petra F G ^e   de Melker, Hester E ^a   Brouwers, Elfi E H G ^f   Fennema, Johannes S A ^d   Götz, Hannelore M ^h   Koekenbier, Rik H ^d   Op de Coul, Eline L M ⁱ   Lydia Pars, LydiaL ^c   van Ravesteijn, Sander M ^j   Luijendijk, Ad ^k   Speksnijder, Arjen G C L ^l   Schipper, Maarten ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f South Limburg Public Health Service   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h Public Health Service of the Rotterdam Region   (Netherlands)

ⁱ RIVM Centre for Infectious Disease Control Netherlands   (Netherlands)

^j Rotterdam Rijnmond Public Health Service   (Netherlands)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l Public Health Laboratory Amsterdam   (Netherlands)

more..

Author keywords

Cervical cancer; Chlamydia trachomatis; Human papillomavirus; Sexually transmitted infection; Viral infection

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARCINOGENICITY; CHLAMYDIASIS; CLINICAL TRIAL; COHORT ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; FEMALE GENITAL TRACT INFECTION; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; VAGINAL SWAB; VIRUS DETECTION; VIRUS TYPING; WART VIRUS; ALPHAPAPILLOMAVIRUS; CARCINOGENESIS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COINFECTION; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; NETHERLANDS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CARCINOGENESIS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COINFECTION; FEMALE; HUMANS; INCIDENCE; NETHERLANDS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84964956496     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.496     Document Type: Article

References (23)

1. Ferlay, J., H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127:2893-2917.
2. Safaeian, M., K. Quint, M. Schiffman, A. C. Rodriguez, S. Wacholder, R. Herrero, et al. 2010. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J. Natl. Cancer Inst. 102:1794-1804.
3. Samoff, E., E. H. Koumans, L. E. Markowitz, M. Sternberg, M. K. Sawyer, D. Swan, et al. 2005. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am. J. Epidemiol. 162:668-675.
4. Shew, M. L., J. D. Fortenberry, W. Tu, B. E. Juliar, B. E. Batteiger, B. Qadadri, et al. 2006. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Arch. Pediatr. Adolesc. Med. 160:151-156.
5. Silins, I., W. Ryd, A. Strand, G. Wadell, S. Tornberg, B. G. Hansson, et al. 2005. Chlamydia trachomatis infection and persistence of human papillomavirus. Int. J. Cancer 116:110-115.
6. Koskela, P., T. Anttila, T. Bjorge, A. Brunsvig, J. Dillner, M. Hakama, et al. 2000. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int. J. Cancer 85:35-39.
7. Madeleine, M. M., T. Anttila, S. M. Schwartz, P. Saikku, M. Leinonen, J. J. Carter, et al. 2007. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int. J. Cancer 120:650-655.
8. Smith, J. S., C. Bosetti, N. Munoz, R. Herrero, F. X. Bosch, J. Eluf-Neto, et al. 2004. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int. J. Cancer 111:431-439.
9. Lehtinen, M., K. A. Ault, E. Lyytikainen, J. Dillner, S. M. Garland, D. G. Ferris, et al. 2011. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex. Transm. Infect. 87:372-376.
10. Rositch, A. F., J. Koshiol, M. G. Hudgens, H. Razzaghi, D. M. Backes, J. M. Pimenta, et al. 2013. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int. J. Cancer 133:1271-1285.
11. Bouvard, V., R. Baan, K. Straif, Y. Grosse, B. Secretan, F. El Ghissassi, et al. 2009. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 10:321-322.
12. van den Broek, I. V. F., J. E. van Bergen, E. E. Brouwers, J. S. Fennema, H. M. Gotz, C. J. Hoebe, et al. 2012. Effectiveness of yearly, register based screening for Chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ 345:e4316.
13. Op de Coul, E. L., H. M. Gotz, J. E. Van Bergen, J. S. Fennema, C. J. Hoebe, R. H. Koekenbier, et al. 2012. Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity. Sex. Transm. Dis. 39:97-103.
14. Mollers, M., J. Boot Hein, J. Vriend Henrike, J. King Audrey, V. F. van den Broek Ingrid, E. A. van Bergen Jan, et al. 2013. Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands. Vaccine 31:394-401.
15. Molijn, A., B. Kleter, W. Quint, and L. J. van Doorn. 2005. Molecular diagnosis of human papillomavirus (HPV) infections. J. Clin. Virol. 32(Suppl. 1):S43-S51.
16. Carey, V., S. L. Zeger, and P. J. Diggle. 1993. Modelling multivariate binary data with alternating logistic regressions. Biometrika 80:517-526.
17. Crosby, R. A., R. J. DiClemente, G. M. Wingood, L. F. Salazar, E. Rose, D. Levine, et al. 2004. Associations between sexually transmitted disease diagnosis and subsequent sexual risk and sexually transmitted disease incidence among adolescents. Sex. Transm. Dis. 31:205-208.
18. Sznitman, S. R., M. P. Carey, P. A. Vanable, R. J. DiClemente, L. K. Brown, R. F. Valois, et al. 2010. The impact of community-based sexually transmitted infection screening results on sexual risk behaviors of African American adolescents. J. Adolesc. Health 47:12-19.
19. R Core Team. 2013. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
20. van Buuren, S., and K. Groothuis-Oudshoorn. 2011. mice: multivariate imputation by chained equations in R. J. Stat. Softw. 45:1-67.
21. Paba, P., D. Bonifacio, L. Di Bonito, D. Ombres, C. Favalli, K. Syrjanen, et al. 2008. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology 51:230-234.
22. Horner, P. J., G. S. Wills, R. Reynolds, A. M. Johnson, D. A. Muir, A. Winston, et al. 2013. Effect of time since exposure to Chlamydia trachomatis on Chlamydia antibody detection in women: a cross-sectional study. Sex. Transm. Infect. 89:398-403.
23. Seraceni, S., F. De Seta, C. Colli, R. Del Savio, G. Pesel, V. Zanin, et al. 2014. High prevalence of HPV multiple genotypes in women with persistent Chlamydia trachomatis infection. Infect. Agent Cancer 9:30.